结缔组织病患者血清ACE2水平降低
该研究检测了SLE、SSc、SS和RA患者及健康对照的血清ACE2浓度与活性,发现四种CTD患者ACE2浓度均显著低于健康人,但活性升高;SLE患者ACE2浓度随糖皮质激素剂量增加而升高,活性与SLEDAI评分弱相关。
要点
- SLE、SSc、SS和RA患者血清ACE2浓度均显著低于健康对照。
- CTD患者ACE2活性升高,与浓度变化方向相反。
- SLE患者ACE2浓度随糖皮质激素增加而升高,与其他治疗无关。
核心结论
- CTD患者血清ACE2浓度降低而活性升高,浓度与活性临床意义不同。
- ACE2水平似乎不受大多数治疗影响。
研究设计与样本
- 研究纳入66例SLE、55例SSc、31例SS和31例RA患者及健康对照,检测血清ACE2浓度(ELISA)和活性(荧光法)。
主要发现
- 四种CTD患者ACE2浓度均显著低于健康对照。
- ACE2浓度与特殊临床特征无关,仅狼疮肾炎患者略低于无肾炎者。
- SLE患者ACE2浓度随糖皮质激素增加而升高,与其他治疗无关。
- CTD患者ACE2活性升高,且与SLEDAI评分弱相关。
临床怎么用
- ACE2浓度与活性在CTD中变化不一致,解读时需区分二者。
- SLE患者ACE2浓度受糖皮质激素影响,评估时应考虑用药。
局限性
- 原文未报告样本量以外的研究局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate serum concentration and activity of angiotensin-converting enzyme 2 (ACE2) in patients with connective tissue diseases (CTDs). METHODS: Serum samples from healthy subjects and patients with SLE, systemic sclerosis (SSc), primary Sjögren's syndrome (SS) and RA were collected. The concentration and activity of ACE2 were measured by ELISA and fluorometric method, respectively, and analysed for associations with clinical features and concurrent medications. RESULTS: In total, 66 SLE, 55 SSc, 31 SS and 31 RA patients were involved. ACE2 concentration was significantly decreased in patients with either of the four CTDs compared with healthy subjects. The concentration was not linked to special clinical features expect that it was slightly lower in patients with lupus nephritis than those without. In SLE patients, ACE2 concentration elevated with the increase of glucocorticoids, and was not associated with other treatments. Different from the concentration, ACE2 activity was increased in CTD patients. A weak correlation of ACE2 activity with SLE disease activity index score was also observed. CONCLUSION: The clinical significance of ACE2 concentration and activity looks quite different among CTD patients. Preliminary data suggest ACE2 levels are not affected by most of the treatments.
引用
- Tang X, Geng L, Feng X, et al. Decreased serum ACE2 levels in patients with connective tissue diseases. Rheumatology (Oxford). 2021. PMID: 33369650. doi:10.1093/rheumatology/keaa898
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。